Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2005 1
2006 2
2009 1
2011 3
2013 3
2014 7
2015 5
2016 8
2017 6
2018 6
2019 2
2020 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma.
Bellmunt J, de Wit R, Vaughn DJ, Fradet Y, Lee JL, Fong L, Vogelzang NJ, Climent MA, Petrylak DP, Choueiri TK, Necchi A, Gerritsen W, Gurney H, Quinn DI, Culine S, Sternberg CN, Mai Y, Poehlein CH, Perini RF, Bajorin DF; KEYNOTE-045 Investigators. Bellmunt J, et al. N Engl J Med. 2017 Mar 16;376(11):1015-1026. doi: 10.1056/NEJMoa1613683. Epub 2017 Feb 17. N Engl J Med. 2017. PMID: 28212060 Free PMC article. Clinical Trial.
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial.
Powles T, Csőszi T, Özgüroğlu M, Matsubara N, Géczi L, Cheng SY, Fradet Y, Oudard S, Vulsteke C, Morales Barrera R, Fléchon A, Gunduz S, Loriot Y, Rodriguez-Vida A, Mamtani R, Yu EY, Nam K, Imai K, Homet Moreno B, Alva A; KEYNOTE-361 Investigators. Powles T, et al. Lancet Oncol. 2021 Jul;22(7):931-945. doi: 10.1016/S1470-2045(21)00152-2. Epub 2021 May 26. Lancet Oncol. 2021. PMID: 34051178 Clinical Trial.
The Role of Metastasectomy in Urothelial Carcinoma: Where Are We in 2020?
Lemke E, Sahasrabudhe D, Guancial E, Bylow K, Johnson S, Messing E, Kilari D. Lemke E, et al. Among authors: guancial e. Clin Genitourin Cancer. 2020 Aug;18(4):e478-e483. doi: 10.1016/j.clgc.2020.01.003. Epub 2020 Jan 27. Clin Genitourin Cancer. 2020. PMID: 32085986 Review.
Role of copper transporters in platinum resistance.
Kilari D, Guancial E, Kim ES. Kilari D, et al. Among authors: guancial e. World J Clin Oncol. 2016 Feb 10;7(1):106-13. doi: 10.5306/wjco.v7.i1.106. World J Clin Oncol. 2016. PMID: 26862494 Free PMC article. Review.
The evolving understanding of microRNA in bladder cancer.
Guancial EA, Bellmunt J, Yeh S, Rosenberg JE, Berman DM. Guancial EA, et al. Urol Oncol. 2014 Jan;32(1):41.e31-40. doi: 10.1016/j.urolonc.2013.04.014. Epub 2013 Aug 2. Urol Oncol. 2014. PMID: 23911686 Free PMC article. Review.
Bladder cancer in the elderly patient: challenges and solutions.
Guancial EA, Roussel B, Bergsma DP, Bylund KC, Sahasrabudhe D, Messing E, Mohile SG, Fung C. Guancial EA, et al. Clin Interv Aging. 2015 Jun 10;10:939-49. doi: 10.2147/CIA.S74322. eCollection 2015. Clin Interv Aging. 2015. PMID: 26089655 Free PMC article. Review.
39 results